Obsessed With Measuring Health | Evidation Co-founder & CEO Christine Lemke
Aug 26, 2024
auto_awesome
Christine Lemke, co-founder and CEO of Evidation Health, opens up about her journey driven by personal experiences with chronic pain. She discusses the power of real-world data in improving health outcomes and how her company navigated initial challenges to focus on patient experience. Lemke highlights innovative recruitment strategies, ensuring diversity and participant consent, and the platform’s potential to transform healthcare research. She also shares insights on upcoming advancements and the integration of diverse health data for proactive care.
Christine Lemke emphasizes the importance of real-world data in transforming healthcare by measuring health outcomes beyond clinical settings.
Evidation's patient-centric approach prioritizes individuals' control over their data, fostering trust and engagement in research initiatives.
Deep dives
Understanding Health Through Real-World Data
The significance of real-world health data is emphasized as a transformative approach in healthcare. Evidation promotes the concept that health outcomes and decisions should be informed by the comprehensive data of individuals' everyday lives, rather than solely by clinical environments. Christine Lemke, the co-founder of Evidation, shares her personal struggles with a diagnosed autoimmune condition, highlighting how proper measurement of health episodes could have led to earlier interventions. By connecting millions of participants, Evidation gathers valuable insights that can enhance health programs and research across various medical conditions.
Empowering Patients Through Data Ownership
A core belief at Evidation is that the data collected belongs to the patients, not the company; they are merely custodians of this information. Christine explains that patients should have the agency to choose how their data is utilized and compensated, which fosters trust and transparency in the relationship. The approach actively avoids the pitfalls of data exploitation seen in other models, ensuring patients are made aware of how their data will be used. This patient-centric philosophy is pivotal in driving engagement and encouraging participation in research initiatives.
Revolutionizing Research Recruitment
Evidation's platform dramatically accelerates the recruitment process for clinical studies by leveraging a vast and diverse user base. The ability to quickly access and engage participants has been demonstrated in past initiatives, such as a COVID cohort recruitment that surpassed 100,000 individuals in under a week. This efficient approach provides researchers with a powerful tool to reach populations that traditional sites often struggle to engage. By directly addressing individual patients, the platform fills a critical gap in clinical study enrollment, thereby enhancing the speed and efficacy of medical research.
In this episode, Christine Lemke, co-founder and CEO of Evidation Health, shares how her personal struggles with chronic pain fueled her mission to transform how we measure and improve health outcomes. She shares the company's evolution and innovative approach to generating real-world evidence (RWE) using a global research platform serving millions of people.
We cover:
- The power of real-world data and understanding health outside the clinic
- Lessons from pivots: Evidation's journey to its current focus
- How they recruit diverse participants, prioritize consent, and even compensate individuals
- Accelerating research and making it more representative of the populations drugs will actually serve
- Where the company's unique data platform goes next, and how it could change healthcare